|
|
|
| ||||||||||
|
QUALITY OF CARE In Senegal, the Population Council evaluated a national program to determine the feasibility of and strategies for scaling up the use of Norplant® (a hormone-based contraceptive implanted in women’s arms) or making a transition to Jadelle® (a similar product with two instead of six rods). The study’s objectives were to assess quality of care, method acceptability, and percentage of contraceptive users choosing and continuing to use implants; and to obtain a profile of implant users. A crucial aspect of the study was locating women who have had Norplant in place for over five years and were lost to follow-up by their health care providers. In Ethiopia, the effect on contraceptive use of expanding access to coital-dependent methods was assessed. The study emphasizes the importance of dual protection from pregnancy and sexually transmitted infections. It also explored whether the introduction/reintroduction of these methods will strengthen the quality of youth-centered services and expand contraceptive choice by assuring adequate contraceptive stocks, increasing knowledge of family planning, offering dual protection, and removing barriers that impede access to all methods. In the Copperbelt Province of Zambia, the scaling up of a package of integrated service delivery assessed whether the methods used in the demonstration pilot study could be replicated in a wider setting, with the ultimate goal of enhancing contraceptive choice and quality of care nationwide. Also in Zambia, the Population Council undertook a study to test whether continuation of contraceptive use was increased and unintended pregnancies reduced with greater choice of methods. To test this hypothesis, the study made use of the pilot introduction of Norplant and the reintroduction of the injectable contraceptive Depo-Provera within Zambia’s family planning program. Two groups of clinics in which contraceptives were added to the existing program methods were compared to a control group of clinics with an unchanged method mix. In one group of experimental clinics, Norplant and Depo-Provera were added to the method mix, and in the second group of clinics only Depo-Provera was added. Eight public-sector clinics in Lusaka City participated in the study; two in each of the experimental groups and four in the control group. Data are being analyzed. Locations Population Council
researchers Non-Council
collaborators Bolivia Dominican Republic Ethiopia Ghana Guatemala Honduras Jamaica Kazakhstan Mexico Nigeria Norway Portugal Senegal Sweden United States Zambia Latin America and the Caribbean Donor Publications/Resources on this issue This page updated |
|
||||||||||
